Yale University

Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies.

TitlePrognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies.
Publication TypeJournal Article
Year of Publication2007
AuthorsMay, Margaret, Jonathan A. C. Sterne, Caroline Sabin, Dominique Costagliola, Amy C. Justice, Rodolphe ThiƩbaut, John Gill, Andrew Phillips, Peter Reiss, Robert Hogg, Bruno Ledergerber, Antonella d'Arminio Monforte, Norbert Schmeisser, Shlomo Staszewski, and Matthias Egger
Corporate AuthorsAntiretroviral Therapy(ART) Cohort Collaboration
JournalAIDS (London, England)
Volume21
Issue9
Pagination1185-97
Date Published2007 May 31
ISSN0269-9370
KeywordsAcquired Immunodeficiency Syndrome, Adolescent, Adult, Age Distribution, Antiretroviral Therapy, Highly Active, Canada, CD4 Lymphocyte Count, Europe, Female, HIV Infections, HIV-1, Humans, Incidence, Male, Middle Aged, Prognosis, Prospective Studies, Risk Factors, RNA, Viral, Sex Distribution, United States, Viral Load
AbstractTo estimate the prognosis over 5 years of HIV-1-infected, treatment-naive patients starting HAART, taking into account the immunological and virological response to therapy.
DOI10.1111/j.1530-0277.2011.01601.x
Alternate JournalAIDS

External Links